Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study

Glycomacropeptide (GMP) represents a good alternative protein source in Phenylketonuria (PKU). In a mouse model, it has been suggested to exert a prebiotic role on beneficial gut bacteria. In this study, we performed the 16S rRNA sequencing to evaluate the effect of 6 months of GMP supplementation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Montanari, Chiara, Ceccarani, Camilla, Corsello, Antonio, Zuvadelli, Juri, Ottaviano, Emerenziana, Dei Cas, Michele, Banderali, Giuseppe, Zuccotti, Gianvincenzo, Borghi, Elisa, Verduci, Elvira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104775/
https://www.ncbi.nlm.nih.gov/pubmed/35565850
http://dx.doi.org/10.3390/nu14091883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104775/
https://www.ncbi.nlm.nih.gov/pubmed/35565850
http://dx.doi.org/10.3390/nu14091883

Ejemplares similares